GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zura Bio Ltd (STU:94E) » Definitions » Ending Cash Position

Zura Bio (STU:94E) Ending Cash Position : €157.78 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Zura Bio Ending Cash Position?

Zura Bio's Ending Cash Position for the quarter that ended in Mar. 2025 was €157.78 Mil.

Zura Bio's quarterly Ending Cash Position declined from Sep. 2024 (€169.59 Mil) to Dec. 2024 (€168.56 Mil) and declined from Dec. 2024 (€168.56 Mil) to Mar. 2025 (€157.78 Mil).

Zura Bio's annual Ending Cash Position increased from Mar. 2022 (€0.00 Mil) to Dec. 2023 (€91.52 Mil) and increased from Dec. 2023 (€91.52 Mil) to Dec. 2024 (€168.56 Mil).

Zura Bio Ending Cash Position Historical Data

The historical data trend for Zura Bio's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zura Bio Ending Cash Position Chart

Zura Bio Annual Data
Trend Mar22 Dec23 Dec24
Ending Cash Position
- 91.52 168.56

Zura Bio Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.63 175.06 169.59 168.56 157.78

Zura Bio Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Zura Bio's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=95.316+73.24
=168.56

Zura Bio's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=163.26+-5.484
=157.78

Zura Bio Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Zura Bio's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Zura Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zura Bio Ltd (STU:94E) » Definitions » Ending Cash Position
Comparable Companies
HLVX ORMP VXRT KYTX TCRX BDTX VOR EXOZ ATOS PLRX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
ZURA:USA
Address
1489 W. Warm Springs Road, Suite 110, Henderson, NV, USA, 89014
Website
https://www.zurabio.com
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Zura Bio Headlines

No Headlines